Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia Xiao-Rui WangYan ChangYan-Rong Liu Original Article 04 January 2020 Pages: 215 - 221
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report Jae-Cheol JoSeok Jin Kimand Consortium for Improving Survival of Lymphoma (CISL) Original Article 18 December 2019 Pages: 223 - 228
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases Nicolas ValletMarjan ErtaultEmmanuel Gyan Original Article 06 January 2020 Pages: 229 - 239
Clinicopathological features of in situ follicular neoplasm and relations with follicular lymphoma in Japan Satoko OgataHiroaki MiyoshiKoichi Ohshima Original Article 02 January 2020 Pages: 241 - 253
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma Young-Woong WonHyewon LeeJae-Cheol Jo Original Article 02 January 2020 Pages: 255 - 264
Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience Malte RoerdenMartin SöklerJuliane S. Walz Original Article 02 January 2020 Pages: 265 - 276
The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments Alessia BariRaffaella MarcheselliFondazione Italiana Linfomi (Onlus) Original Article Open access 23 December 2019 Pages: 277 - 282
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study Luigi RigacciBenedetta PucciniPier Luigi Zinzani Original Article 23 December 2019 Pages: 283 - 291
The prognostic significance of ΔSUVmax assessed by PET/CT scan after 2 cycles of chemotherapy in patients with classic Hodgkin’s lymphoma Shenmiao YangLiheng QiuJin Lu Original Article 03 January 2020 Pages: 293 - 299
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience Murat ÖzbalakAyşe SalihoğluBurhan Ferhanoglu Original Article 17 December 2019 Pages: 301 - 307
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study) Jae-Cheol JoHo Sup Leethe Korean Multiple Myeloma Working Party (KMMWP) Original Article 23 December 2019 Pages: 309 - 319
Treatment evolution and improved survival in multiple myeloma in Taiwan Chao-Hsiun TangHsin-An HouYanfang Liu Original Article Open access 05 December 2019 Pages: 321 - 330
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant Massimo MartinoMercedes GoriAnnalisa Pitino Original Article 18 December 2019 Pages: 331 - 341
Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT Guangqiang MengJingshi WangZhao Wang Original Article 26 December 2019 Pages: 343 - 349
Acute myelomonocytic leukemia with uncommon morphological features Nicolas FreynetSihem TarfiOrianne Wagner-Ballon Letter to the Editor 08 January 2020 Pages: 351 - 352
Spontaneous molecular response of IDH2 acute myeloid leukemia Sabine Khalife-HachemJean PegliascoJean-Baptiste Micol Letter to the Editor 09 December 2019 Pages: 353 - 354
Pregnancy exposure to midostaurin in the first trimester Soumya OjhaMelissa G Ooi Letter to the Editor 03 January 2020 Pages: 355 - 356
An uncommon presentation of chronic myeloid leukemia Joseph S. ChristiansenManila GaddhJill Wells Letter to the Editor 02 December 2019 Pages: 357 - 358
The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study Hirotaka MoriMasumi SukegawaTakayuki Ikezoe Letter to the Editor 23 December 2019 Pages: 359 - 361
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia Giovanni CaocciMarianna GrecoGiorgio La Nasa Letter to the Editor 06 December 2019 Pages: 363 - 365
Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment Sara SantosCarlos BernardesGonçalo Ramos Letter to the Editor 26 November 2019 Pages: 367 - 369
Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia Yu QiuHao CaiXin-xin Cao Letter to the Editor 17 December 2019 Pages: 371 - 373
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma Frida SchainAnnica DominicusMagnus Björkholm Letter to the Editor Open access 10 December 2019 Pages: 375 - 376
Clonal evolution of one rare case of multiple myeloma with bilateral testicular mass as initial presentation Na LinYongli WuRui Zhang Letter to the Editor 26 December 2019 Pages: 377 - 378
Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma Mathieu MeunierAyoub LarabiJean Yves Cahn Letter to the Editor 10 December 2019 Pages: 379 - 380
Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome Shoko NakayamaYasuyoshi MoritaItaru Matsumura Letter to the Editor 25 November 2019 Pages: 381 - 383
Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma Joycelyn P. Y. SimRex Au-YeungYok-Lam Kwong Letter to the Editor 26 November 2019 Pages: 385 - 388
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation Kyosuke YamaguchiYasushi KubotaShinya Kimura Letter to the Editor 17 December 2019 Pages: 389 - 390
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma Carlos Bravo-PerezInmaculada PajaresFrancisco Jose Ortuño Letter to the Editor 20 December 2019 Pages: 391 - 393
Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen Xiang ZhangJianhu LiWenjuan Yu Letter to the Editor 26 December 2019 Pages: 395 - 397
